rs1555968941
Variant summary
Our verdict is Pathogenic. The variant received 14 ACMG points: 14P and 0B. PM2PM5PP3_ModeratePP5_Very_Strong
The NM_000719.7(CACNA1C):c.4087G>A(p.Val1363Met) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 12/21 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. V1363L) has been classified as Pathogenic.
Frequency
Consequence
NM_000719.7 missense
Scores
Clinical Significance
Conservation
Publications
- Timothy syndromeInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet, G2P, Labcorp Genetics (formerly Invitae)
- neurodevelopmental disorder with hypotonia, language delay, and skeletal defects with or without seizuresInheritance: AD Classification: STRONG Submitted by: Ambry Genetics
- long QT syndromeInheritance: AD Classification: MODERATE Submitted by: ClinGen
- long QT syndrome 8Inheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
- Brugada syndromeInheritance: AD Classification: SUPPORTIVE, NO_KNOWN Submitted by: Orphanet, ClinGen
- Brugada syndrome 3Inheritance: AD Classification: LIMITED, NO_KNOWN Submitted by: Ambry Genetics, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
- intellectual disabilityInheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
- short QT syndromeInheritance: AD Classification: LIMITED, NO_KNOWN Submitted by: Ambry Genetics, ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 14 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CACNA1C | NM_000719.7 | c.4087G>A | p.Val1363Met | missense_variant | Exon 33 of 47 | ENST00000399655.6 | NP_000710.5 | |
CACNA1C | NM_001167623.2 | c.4087G>A | p.Val1363Met | missense_variant | Exon 33 of 47 | ENST00000399603.6 | NP_001161095.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CACNA1C | ENST00000399603.6 | c.4087G>A | p.Val1363Met | missense_variant | Exon 33 of 47 | 5 | NM_001167623.2 | ENSP00000382512.1 | ||
CACNA1C | ENST00000399655.6 | c.4087G>A | p.Val1363Met | missense_variant | Exon 33 of 47 | 1 | NM_000719.7 | ENSP00000382563.1 | ||
CACNA1C | ENST00000682544.1 | c.4321G>A | p.Val1441Met | missense_variant | Exon 35 of 50 | ENSP00000507184.1 | ||||
CACNA1C | ENST00000406454.8 | c.4087G>A | p.Val1363Met | missense_variant | Exon 33 of 48 | 5 | ENSP00000385896.3 | |||
CACNA1C | ENST00000399634.6 | c.4054G>A | p.Val1352Met | missense_variant | Exon 32 of 47 | 5 | ENSP00000382542.2 | |||
CACNA1C | ENST00000683824.1 | c.4252G>A | p.Val1418Met | missense_variant | Exon 34 of 48 | ENSP00000507867.1 | ||||
CACNA1C | ENST00000347598.9 | c.4231G>A | p.Val1411Met | missense_variant | Exon 35 of 49 | 1 | ENSP00000266376.6 | |||
CACNA1C | ENST00000344100.7 | c.4153G>A | p.Val1385Met | missense_variant | Exon 33 of 47 | 1 | ENSP00000341092.3 | |||
CACNA1C | ENST00000327702.12 | c.4087G>A | p.Val1363Met | missense_variant | Exon 33 of 48 | 1 | ENSP00000329877.7 | |||
CACNA1C | ENST00000399617.6 | c.4087G>A | p.Val1363Met | missense_variant | Exon 33 of 48 | 5 | ENSP00000382526.1 | |||
CACNA1C | ENST00000682462.1 | c.4177G>A | p.Val1393Met | missense_variant | Exon 33 of 47 | ENSP00000507105.1 | ||||
CACNA1C | ENST00000683781.1 | c.4177G>A | p.Val1393Met | missense_variant | Exon 33 of 47 | ENSP00000507434.1 | ||||
CACNA1C | ENST00000683840.1 | c.4177G>A | p.Val1393Met | missense_variant | Exon 33 of 47 | ENSP00000507612.1 | ||||
CACNA1C | ENST00000683956.1 | c.4177G>A | p.Val1393Met | missense_variant | Exon 33 of 47 | ENSP00000506882.1 | ||||
CACNA1C | ENST00000399638.5 | c.4171G>A | p.Val1391Met | missense_variant | Exon 34 of 48 | 1 | ENSP00000382547.1 | |||
CACNA1C | ENST00000335762.10 | c.4162G>A | p.Val1388Met | missense_variant | Exon 34 of 48 | 5 | ENSP00000336982.5 | |||
CACNA1C | ENST00000399606.5 | c.4147G>A | p.Val1383Met | missense_variant | Exon 34 of 48 | 1 | ENSP00000382515.1 | |||
CACNA1C | ENST00000399621.5 | c.4087G>A | p.Val1363Met | missense_variant | Exon 33 of 47 | 1 | ENSP00000382530.1 | |||
CACNA1C | ENST00000399637.5 | c.4087G>A | p.Val1363Met | missense_variant | Exon 33 of 47 | 1 | ENSP00000382546.1 | |||
CACNA1C | ENST00000402845.7 | c.4087G>A | p.Val1363Met | missense_variant | Exon 33 of 47 | 1 | ENSP00000385724.3 | |||
CACNA1C | ENST00000399629.5 | c.4138G>A | p.Val1380Met | missense_variant | Exon 33 of 47 | 1 | ENSP00000382537.1 | |||
CACNA1C | ENST00000682336.1 | c.4129G>A | p.Val1377Met | missense_variant | Exon 33 of 47 | ENSP00000507898.1 | ||||
CACNA1C | ENST00000399591.5 | c.4054G>A | p.Val1352Met | missense_variant | Exon 32 of 46 | 1 | ENSP00000382500.1 | |||
CACNA1C | ENST00000399595.5 | c.4054G>A | p.Val1352Met | missense_variant | Exon 32 of 46 | 1 | ENSP00000382504.1 | |||
CACNA1C | ENST00000399649.5 | c.4048G>A | p.Val1350Met | missense_variant | Exon 32 of 46 | 1 | ENSP00000382557.1 | |||
CACNA1C | ENST00000399597.5 | c.4087G>A | p.Val1363Met | missense_variant | Exon 33 of 47 | 1 | ENSP00000382506.1 | |||
CACNA1C | ENST00000399601.5 | c.4087G>A | p.Val1363Met | missense_variant | Exon 33 of 47 | 1 | ENSP00000382510.1 | |||
CACNA1C | ENST00000399641.6 | c.4087G>A | p.Val1363Met | missense_variant | Exon 33 of 47 | 1 | ENSP00000382549.1 | |||
CACNA1C | ENST00000399644.5 | c.4087G>A | p.Val1363Met | missense_variant | Exon 33 of 47 | 1 | ENSP00000382552.1 | |||
CACNA1C | ENST00000682835.1 | c.4087G>A | p.Val1363Met | missense_variant | Exon 33 of 47 | ENSP00000507282.1 | ||||
CACNA1C | ENST00000683482.1 | c.4078G>A | p.Val1360Met | missense_variant | Exon 33 of 47 | ENSP00000507169.1 | ||||
CACNA1C | ENST00000682686.1 | c.4054G>A | p.Val1352Met | missense_variant | Exon 32 of 46 | ENSP00000507309.1 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome Cov.: 30
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
not provided Pathogenic:2
- -
The V1363M variant in the CACNA1C gene has not been reported previously as a pathogenic variant, nor as a benign variant, to our knowledge. The V1363M variant is not observed in large population cohorts (Lek et al., 2016; 1000 Genomes Consortium et al., 2015; Exome Variant Server). The V1363M variant is a conservative amino acid substitution, which is not likely to impact secondary protein structure as these residues share similar properties. However, this substitution occurs at a position that is conserved across species, and in silico analysis predicts this variant is probably damaging to the protein structure/function. We interpret V1363M as a likely pathogenic variant. -
Neurodevelopmental disorder with hypotonia, language delay, and skeletal defects with or without seizures Pathogenic:1
- -
CACNA1C-related disorder Other:1
Variant interpretted as Likely pathogenic and reported on 07/24/2017 by GTR ID 26957. GenomeConnect assertions are reported exactly as they appear on the patient-provided report from the testing laboratory. GenomeConnect staff make no attempt to reinterpret the clinical significance of the variant. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at